Top of this page
Skip navigation, go straight to the content
Executive Committee
Jean-Christophe Tellier
Chief Executive Officer &
Chairman of the Executive Committee
Joined UCB in June 2011
Appointed as CEO in January 2015
Emmanuel Caeymaex
Executive Vice President
Immunology Solutions & Head of US
Joined UCB in March 1994
Appointed in February 2015
Jean-Luc Fleurial
Executive Vice President &
Chief Human Resources Officer
Joined UCB in September 2017
Appointed in September 2017
Iris Loew-Friedrich
Executive Vice President &
Chief Medical Officer
Joined UCB in September 2006
Appointed in March 2008
Kirsten Lund-Jurgensen
Executive Vice President,
Supply & Technology Solutions
Joined UCB in 2019
Appointed in September 2019
Dhavalkumar Patel
Executive Vice President &
Chief Scientific Officer
Joined UCB in October 2017
Appointed in October 2017
Bill Silbey
Executive Vice-President &
General Counsel
Joined UCB in 2011
Appointed in March 2019
Charl van Zyl
Executive Vice President Neurology Solutions & Head of EU/International
Joined UCB in March 2017
Appointed in March 2017
CFO transition
Detlef Thielgen stepped down from the Executive Committee as of 10 April 2020.
Sandrine Dufour will join UCB and take over the CFO position as of 1 July 2020.
Jean-Christophe Tellier will ensure the interim role of CFO in the meantime.